Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
24/07/2012	14h00	PR Newswire (US)	Insmed to Host 2012 Second Quarter Earnings Conference Call	NASDAQ:INSM	Insmed Inc
11/07/2012	12h04	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:INSM	Insmed Inc
10/07/2012	14h00	PR Newswire (US)	Insmed To Present At JMP Securities 7th Annual Healthcare Conference	NASDAQ:INSM	Insmed Inc
09/07/2012	22h32	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:INSM	Insmed Inc
06/07/2012	16h56	Dow Jones News	Registration Effectiveness Orders Issued by the SEC	NASDAQ:INSM	Insmed Inc
06/07/2012	12h02	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:INSM	Insmed Inc
02/07/2012	14h00	PR Newswire (US)	Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital	NASDAQ:INSM	Insmed Inc
27/06/2012	14h00	PR Newswire (US)	Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycob...	NASDAQ:INSM	Insmed Inc
15/06/2012	15h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
14/06/2012	22h33	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3)	NASDAQ:INSM	Insmed Inc
30/05/2012	14h00	PR Newswire (US)	Insmed Provides Corporate Update	NASDAQ:INSM	Insmed Inc
23/05/2012	14h00	PR Newswire (US)	Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculou...	NASDAQ:INSM	Insmed Inc
16/05/2012	14h00	PR Newswire (US)	Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman	NASDAQ:INSM	Insmed Inc
08/05/2012	14h09	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:INSM	Insmed Inc
08/05/2012	13h00	PR Newswire (US)	Insmed Announces First Quarter 2012 Financial Results	NASDAQ:INSM	Insmed Inc
07/05/2012	14h00	PR Newswire (US)	Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis P...	NASDAQ:INSM	Insmed Inc
24/04/2012	14h00	PR Newswire (US)	Insmed to Host 2012 First Quarter Earnings Conference Call	NASDAQ:INSM	Insmed Inc
16/04/2012	14h00	PR Newswire (US)	Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with...	NASDAQ:INSM	Insmed Inc
10/04/2012	18h34	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:INSM	Insmed Inc
13/03/2012	12h00	PR Newswire (US)	Insmed Announces Fourth Quarter and Full-Year 2011 Financial Results	NASDAQ:INSM	Insmed Inc
13/03/2012	11h31	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:INSM	Insmed Inc
28/02/2012	14h00	PR Newswire (US)	Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call	NASDAQ:INSM	Insmed Inc
10/02/2012	14h00	PR Newswire (US)	Insmed Incorporated Provides Update on Clinical Program for ARIKACE®	NASDAQ:INSM	Insmed Inc
09/02/2012	19h13	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:INSM	Insmed Inc
20/01/2012	14h00	PR Newswire (US)	Insmed Incorporated Provides Corporate Update	NASDAQ:INSM	Insmed Inc
14/11/2011	14h00	PR Newswire (US)	Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference	NASDAQ:INSM	Insmed Inc
08/11/2011	13h00	PR Newswire (US)	Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2011	NASDAQ:INSM	Insmed Inc
25/10/2011	14h00	PR Newswire (US)	Insmed to Host 2011 Third Quarter Earnings Conference Call	NASDAQ:INSM	Insmed Inc
14/10/2011	14h00	PR Newswire (US)	Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication	NASDAQ:INSM	Insmed Inc
10/10/2011	14h00	PR Newswire (US)	Insmed Incorporated Provides Regulatory Update	NASDAQ:INSM	Insmed Inc